. Uprolide P, 13 C-NMR spectrum Figure S26 . Uprolide P, 13 C-NMR DEPT 135 spectrum Figure S27 . Uprolide P, 1 H-1 H-COSY spectrum Figure S28 . Uprolide P, HSQC spectrum Figure S29 . Uprolide P, HMBC spectrum Figure S30 . Uprolide P, 1D NOE irradiation on H-1 Figure S31 . Uprolide P, 1D NOE irradiation on H-7 Figure S32 . Uprolide P, 1D NOE irradiation on H-11 Figure S33 . Uprolide P, 1D NOE irradiation on H-14 Figure S34 . Uprolide P, 1D NOE irradiation on H-19a Figure S35 . Uprolide P, 1D NOE irradiation on H-19b Figure S36 . Uprolide P, 1D NOE irradiation on H-20 Figure S37 . Uprolide N, HRESITOF-MS Figure S38 . Uprolide O, ESI-TOF-MS Figure S39 . Uprolide P, ESI-TOF-MS Figure S40 . Uprolide N IR spectrum Figure S41 . Uprolide O IR spectrum Figure S42 . Uprolide P IR spectrum Figure S43 . Dolabellane, 1 H-NMR spectrum Figure S44 . Dolabellane, 13 C-NMR spectrum Figure S45 . Dolabellane, LRAPCI-MS Figure S46 . Uprolides N, O and P inhibit the production of inflammatory mediators induced by LPS in murine macrophages Figure S47 : Compounds N and P do not induced the production of TNF and IL-6 Figure S46 . Uprolides N, O and P inhibit the production of inflammatory mediators induced by LPS in murine macrophages. IC50 sigmoidal curves calculated by the statistical software package GraphPad Prism 5 from a representative experiments of two Graphs represent the sigmoidal curves for the IC50 calculation of TNF (left column) and IL-6 (right column) induced by LPS in the presence of the uprolides N, O or P. Results represent means ± S.D. from stimuli performed in duplicates. Figure S47 . Compound N and P do not induced the production of TNF and IL-6. Macrophages from C57B1/6 mice were treated with 7 μM of compounds 1 or 3 (uprolides N or P) 1 h before stimulation with 100 g/mL of LPS. The supernatants were harvested after 16 h, and cytokine  concentrations were determined by ELISA. The cell viability was assessed using MTT assay after collecting the supernatants. Results are represented as Mean ± SD from stimuli performed in duplicate.
